Biocon drug for COVID 19 ALZUMAb® (Itolizumab) to cost Rs 7,950 per vial


Biocon Ltd, an innovation-led global biopharmaceuticals company, presenting its key insights into the results of the Itolizumab for treating patients with moderate to severe COVID-19 complications informed that per vial is priced at Rs 7950 in a virtual press conference. The biotechnology major informed that each ALZUMAb® (Itolizumab) injection is presented as a 25mg/5mL solution, […]

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

To Top